Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Bariatric surgery "worthy investment" for NHS Italy

    • 1 Accesses

    This is a preview of subscription content, log in to check access.

    Notes

    1. 1.

      The study was funded by Johnson & Johnson Medical SpA.

    Reference

    1. Rognoni C, et al. Cost-Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet. Clinical Therapeutics : 17 Jan 2020. Available from: URL: http://doi.org/10.1016/j.clinthera.2019.12.001

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Bariatric surgery "worthy investment" for NHS Italy. PharmacoEcon Outcomes News 846, 6 (2020). https://doi.org/10.1007/s40274-020-6545-7

    Download citation